Pfizer Inc. Boosts Q3 2024 Earnings Outlook: Insights from Leerink Partners
Friday, 2 August 2024, 11:18
Pfizer's Earnings Update
Equity researchers at Leerink Partners have increased their expectations for Pfizer Inc. (NYSE:PFE) regarding its Q3 2024 earnings.
Details of the Update
- The report was issued to investors on Wednesday, July 31st.
- Analyst D. Risinger now anticipates a favorable outcome for Pfizer’s earnings per share.
Conclusion
This upgrade in expectations highlights the potential positive performance of Pfizer Inc. in the upcoming financial period and serves as a reliable indicator for investors.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.